- $49.33bn
- $53.04bn
- $9.46bn
- 93
- 17
- 92
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,508 | 6,833 | 8,291 | 8,717 | 9,455 |
Cost of Revenue | |||||
Gross Profit | 3,656 | 3,091 | 4,696 | 4,809 | 5,254 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,701 | 7,319 | 7,717 | 8,066 | 8,429 |
Operating Profit | -193 | -486 | 574 | 651 | 1,026 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -332 | -635 | 418 | 463 | 832 |
Provision for Income Taxes | |||||
Net Income After Taxes | -656 | -531 | 376 | 335 | 974 |
Net Income Before Extraordinary Items | |||||
Net Income | -656 | -531 | 376 | 335 | 974 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -656 | -531 | 376 | 335 | 974 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.02 | -0.09 | 1.82 | 0.176 | 1.42 |
Dividends per Share |